vs

Side-by-side financial comparison of Baird Medical Investment Holdings Ltd (BDMD) and CHAIN BRIDGE BANCORP INC (CBNA). Click either name above to swap in a different company.

CHAIN BRIDGE BANCORP INC is the larger business by last-quarter revenue ($14.7M vs $8.0M, roughly 1.8× Baird Medical Investment Holdings Ltd). CHAIN BRIDGE BANCORP INC runs the higher net margin — 36.4% vs -142.7%, a 179.1% gap on every dollar of revenue. CHAIN BRIDGE BANCORP INC produced more free cash flow last quarter ($11.5M vs $-3.2M).

Baird Medical Investment Holdings Ltd is a healthcare-focused investment holding company mainly operating in the Chinese market. It invests in and manages businesses covering in vitro diagnostic devices, medical consumables, and community healthcare services, serving clinical institutions and individual consumers.

Suburban Bancorp, Inc. was a publicly traded multibank holding company headquartered in suburban Chicago. It was founded by Gerald F. Fitzgerald, father of former U.S. Senator Peter Fitzgerald, and majority owned by the Fitzgerald family. Bank of Montreal acquired Suburban Bancorp, Inc. by merger in 1994. Harris Bankmont, Inc., an American subsidiary of Bank of Montreal, merged with Suburban Bankcorp to expand the Harris Bank presence in the Chicago area. The all-stock deal was valued at $246...

BDMD vs CBNA — Head-to-Head

Bigger by revenue
CBNA
CBNA
1.8× larger
CBNA
$14.7M
$8.0M
BDMD
Higher net margin
CBNA
CBNA
179.1% more per $
CBNA
36.4%
-142.7%
BDMD
More free cash flow
CBNA
CBNA
$14.7M more FCF
CBNA
$11.5M
$-3.2M
BDMD

Income Statement — Q2 FY2025 vs Q4 FY2025

Metric
BDMD
BDMD
CBNA
CBNA
Revenue
$8.0M
$14.7M
Net Profit
$-11.4M
$5.3M
Gross Margin
82.1%
Operating Margin
-131.3%
45.6%
Net Margin
-142.7%
36.4%
Revenue YoY
Net Profit YoY
EPS (diluted)
$0.81

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BDMD
BDMD
CBNA
CBNA
Q4 25
$14.7M
Q3 25
$13.1M
Q2 25
$8.0M
$12.6M
Q1 25
$14.5M
Q3 24
$16.7M
Net Profit
BDMD
BDMD
CBNA
CBNA
Q4 25
$5.3M
Q3 25
$4.7M
Q2 25
$-11.4M
$4.6M
Q1 25
$5.6M
Q3 24
$7.5M
Gross Margin
BDMD
BDMD
CBNA
CBNA
Q4 25
Q3 25
Q2 25
82.1%
Q1 25
Q3 24
Operating Margin
BDMD
BDMD
CBNA
CBNA
Q4 25
45.6%
Q3 25
44.9%
Q2 25
-131.3%
45.8%
Q1 25
48.4%
Q3 24
56.3%
Net Margin
BDMD
BDMD
CBNA
CBNA
Q4 25
36.4%
Q3 25
35.8%
Q2 25
-142.7%
36.3%
Q1 25
38.6%
Q3 24
44.8%
EPS (diluted)
BDMD
BDMD
CBNA
CBNA
Q4 25
$0.81
Q3 25
$0.72
Q2 25
$0.70
Q1 25
$0.85
Q3 24
$1.64

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BDMD
BDMD
CBNA
CBNA
Cash + ST InvestmentsLiquidity on hand
$586.6M
Total DebtLower is stronger
$8.4M
Stockholders' EquityBook value
$35.6M
$169.2M
Total Assets
$77.0M
$1.8B
Debt / EquityLower = less leverage
0.24×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BDMD
BDMD
CBNA
CBNA
Q4 25
$586.6M
Q3 25
$395.7M
Q2 25
$377.3M
Q1 25
$629.2M
Q3 24
$639.8M
Total Debt
BDMD
BDMD
CBNA
CBNA
Q4 25
Q3 25
Q2 25
$8.4M
Q1 25
Q3 24
Stockholders' Equity
BDMD
BDMD
CBNA
CBNA
Q4 25
$169.2M
Q3 25
$163.1M
Q2 25
$35.6M
$156.9M
Q1 25
$151.5M
Q3 24
$104.8M
Total Assets
BDMD
BDMD
CBNA
CBNA
Q4 25
$1.8B
Q3 25
$1.5B
Q2 25
$77.0M
$1.4B
Q1 25
$1.7B
Q3 24
$1.6B
Debt / Equity
BDMD
BDMD
CBNA
CBNA
Q4 25
Q3 25
Q2 25
0.24×
Q1 25
Q3 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BDMD
BDMD
CBNA
CBNA
Operating Cash FlowLast quarter
$-3.2M
$15.6M
Free Cash FlowOCF − Capex
$-3.2M
$11.5M
FCF MarginFCF / Revenue
-40.7%
78.1%
Capex IntensityCapex / Revenue
0.6%
28.0%
Cash ConversionOCF / Net Profit
2.92×
TTM Free Cash FlowTrailing 4 quarters
$17.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BDMD
BDMD
CBNA
CBNA
Q4 25
$15.6M
Q3 25
$2.8M
Q2 25
$-3.2M
$3.4M
Q1 25
$3.1M
Q3 24
Free Cash Flow
BDMD
BDMD
CBNA
CBNA
Q4 25
$11.5M
Q3 25
$2.5M
Q2 25
$-3.2M
$2.5M
Q1 25
$1.4M
Q3 24
FCF Margin
BDMD
BDMD
CBNA
CBNA
Q4 25
78.1%
Q3 25
18.7%
Q2 25
-40.7%
20.0%
Q1 25
9.8%
Q3 24
Capex Intensity
BDMD
BDMD
CBNA
CBNA
Q4 25
28.0%
Q3 25
2.5%
Q2 25
0.6%
6.5%
Q1 25
11.6%
Q3 24
Cash Conversion
BDMD
BDMD
CBNA
CBNA
Q4 25
2.92×
Q3 25
0.59×
Q2 25
0.73×
Q1 25
0.55×
Q3 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons